INPREMZIA Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for INPREMZIA with the United States Patent and Trademark Office. The USPTO has given the INPREMZIA trademark a serial number of 87287579. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 25, 2019. This trademark is owned by Baxter International Inc.. The INPREMZIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin
inpremzia

General Information

Serial Number87287579
Word MarkINPREMZIA
Filing DateTuesday, January 3, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, November 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2019EXTENSION 4 GRANTED
Thursday, April 4, 2019EXTENSION 4 FILED
Thursday, April 4, 2019TEAS EXTENSION RECEIVED
Friday, January 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 3 GRANTED
Thursday, October 25, 2018EXTENSION 3 FILED
Wednesday, January 16, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 31, 2018NOTICE OF REVIVAL - E-MAILED
Tuesday, October 30, 2018EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 30, 2018PETITION TO REVIVE-GRANTED
Tuesday, October 30, 2018TEAS PETITION TO REVIVE RECEIVED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 25, 2018EXTENSION 2 GRANTED
Wednesday, April 25, 2018EXTENSION 2 FILED
Wednesday, April 25, 2018TEAS EXTENSION RECEIVED
Wednesday, October 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2017EXTENSION 1 GRANTED
Monday, October 23, 2017EXTENSION 1 FILED
Monday, October 23, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2017ASSIGNED TO EXAMINER
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 6, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

inpremzia pharmaceutical disorders diseases preparations insulin containing metabolic diabetes products namely